Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 537

1.

Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry - A tutorial.

El Amrani M, Donners AAM, Hack CE, Huitema ADR, van Maarseveen EM.

Anal Chim Acta. 2019 Nov 8;1080:22-34. doi: 10.1016/j.aca.2019.05.076. Epub 2019 Jun 11. Review.

PMID:
31409472
2.

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema.

Hofman ZLM, van West N, Hack CE, Knulst AC, Maas C, Röckmann H.

Clin Transl Allergy. 2019 Jul 12;9:35. doi: 10.1186/s13601-019-0274-7. eCollection 2019.

3.

Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study.

van Helvoort EM, Popov-Celeketic J, Eijkelkamp N, Coeleveld K, Tryfonidou MA, Wijne CD, Hack CE, Lafeber FPJG, Mastbergen SC.

PLoS One. 2019 Jul 11;14(7):e0219587. doi: 10.1371/journal.pone.0219587. eCollection 2019.

4.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Jun 13. doi: 10.1111/ajt.15493. [Epub ahead of print]

PMID:
31194283
5.

Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis.

Shan L, van den Hoogen LL, Meeldijk J, Kok HM, Jongeneel LH, Boes M, Wenink MH, Hack CE, Radstake TRDJ, van Roon JAG, Bovenschen N.

Clin Exp Rheumatol. 2019 Jun 6. [Epub ahead of print]

PMID:
31172927
6.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Jun 2. doi: 10.1111/ajt.15486. [Epub ahead of print]

PMID:
31155833
7.

Inflammatory response and optimalisation of perioperative fluid administration during hyperthermic intraoperative intraperitoneal chemotherapy surgery.

de Witte P, de Witt CA, van de Minkelis JL, Boerma D, Solinger HF, Hack CE, Bruins P.

J Gastrointest Oncol. 2019 Apr;10(2):244-253. doi: 10.21037/jgo.2018.12.09.

8.

An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking water.

Clewell HJ 3rd, Gentry PR, Hack CE, Greene T, Clewell RA.

Regul Toxicol Pharmacol. 2019 Apr;103:237-252. doi: 10.1016/j.yrtph.2019.01.028. Epub 2019 Jan 29. Review.

9.

The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation.

Budding K, van Setten J, van de Graaf EA, van Rossum OA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, Oudijk ED, Hack CE, Otten HG.

Front Immunol. 2019 Jan 17;9:3105. doi: 10.3389/fimmu.2018.03105. eCollection 2018.

10.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

11.

Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.

van de Groep K, Nierkens S, Cremer OL, Peelen LM, Klein Klouwenberg PMC, Schultz MJ, Hack CE, van der Poll T, Bonten MJM, Ong DSY; MARS consortium.

Crit Care. 2018 Dec 18;22(1):348. doi: 10.1186/s13054-018-2261-0.

12.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
13.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
14.

IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.

Steen-Louws C, Hartgring SAY, Popov-Celeketic J, Lopes AP, de Smet MBM, Eijkelkamp N, Lafeber FPJG, Hack CE, van Roon JAG.

Clin Exp Immunol. 2019 Jan;195(1):1-9. doi: 10.1111/cei.13224. Epub 2018 Nov 11.

15.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

16.

Lipid, water, and protein composition to facilitate kinetic modeling of the auditory pathway.

Grobe N, Narayanan L, Brown DN, Law ST, Sibomana I, Shiyanov P, Reo NV, Hack CE, Sterner TR, Mattie DR.

Toxicol Mech Methods. 2019 Jan;29(1):53-59. doi: 10.1080/15376516.2018.1508263. Epub 2018 Sep 27.

PMID:
30084267
17.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

18.

Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.

El Amrani M, Szanto CL, Hack CE, Huitema ADR, Nierkens S, van Maarseveen EM.

Anal Bioanal Chem. 2018 Sep;410(23):5849-5858. doi: 10.1007/s00216-018-1198-0. Epub 2018 Jun 25.

19.

IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.

Steen-Louws C, Popov-Celeketic J, Mastbergen SC, Coeleveld K, Hack CE, Eijkelkamp N, Tryfonidou M, Spruijt S, van Roon JAG, Lafeber FPJG.

Osteoarthritis Cartilage. 2018 Aug;26(8):1127-1135. doi: 10.1016/j.joca.2018.05.005. Epub 2018 May 26.

20.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

21.

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.

Jacobino SR, Nederend M, Reijneveld JF, Augustijn D, Jansen JHM, Meeldijk J, Reiding KR, Wuhrer M, Coenjaerts FEJ, Hack CE, Bont LJ, Leusen JHW.

MAbs. 2018 Apr;10(3):453-462. doi: 10.1080/19420862.2018.1433974. Epub 2018 Mar 19.

22.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

23.

Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation.

Budding K, van Setten J, van de Graaf EA, van Rossum OA, Kardol-Hoefnagel T, Oudijk ED, Hack CE, Otten HG.

Front Immunol. 2017 Sep 6;8:1109. doi: 10.3389/fimmu.2017.01109. eCollection 2017.

24.

Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema.

Hofman ZLM, de Maat S, Suffritti C, Zanichelli A, van Doorn C, Sebastian SAE, Veszeli N, Csuka D, Renné T, Pasterkamp G, Cicardi M, Farkas H, Hack CE, Maas C.

J Allergy Clin Immunol. 2017 Dec;140(6):1700-1703.e8. doi: 10.1016/j.jaci.2017.07.012. Epub 2017 Aug 4. No abstract available.

PMID:
28782632
25.

A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo.

van Vulpen LFD, Popov-Celeketic J, van Meegeren MER, Coeleveld K, van Laar JM, Hack CE, Schutgens REG, Mastbergen SC, Lafeber FPJG.

J Thromb Haemost. 2017 Sep;15(9):1788-1798. doi: 10.1111/jth.13778. Epub 2017 Aug 17.

26.

Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Oudijk ED, Kwakkel-van Erp JM, Hack CE, Otten HG.

Front Immunol. 2017 Mar 21;8:322. doi: 10.3389/fimmu.2017.00322. eCollection 2017.

27.

A novel proinflammatory role for granzyme A.

van Eck JA, Shan L, Meeldijk J, Hack CE, Bovenschen N.

Cell Death Dis. 2017 Feb 23;8(2):e2630. doi: 10.1038/cddis.2017.56. No abstract available.

28.

Granzymes A and K differentially potentiate LPS-induced cytokine response.

Wensink AC, Kok HM, Meeldijk J, Fermie J, Froelich CJ, Hack CE, Bovenschen N.

Cell Death Discov. 2016 Dec 12;2:16084. doi: 10.1038/cddiscovery.2016.84. eCollection 2016.

29.

CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.

Krukowski K, Eijkelkamp N, Laumet G, Hack CE, Li Y, Dougherty PM, Heijnen CJ, Kavelaars A.

J Neurosci. 2016 Oct 26;36(43):11074-11083.

30.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
31.

Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection.

Jacobino SR, Nederend M, Hennus M, Houben ML, Ngwuta JO, Viveen M, Coenjaerts FEJ, Hack CE, van Neerven RJJ, Graham BS, Bont L, Leusen JHW.

J Allergy Clin Immunol. 2016 Nov;138(5):1477-1480.e5. doi: 10.1016/j.jaci.2016.06.001. Epub 2016 Jun 16. No abstract available.

PMID:
27448445
32.

IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.

Eijkelkamp N, Steen-Louws C, Hartgring SA, Willemen HL, Prado J, Lafeber FP, Heijnen CJ, Hack CE, van Roon JA, Kavelaars A.

J Neurosci. 2016 Jul 13;36(28):7353-63. doi: 10.1523/JNEUROSCI.0092-16.2016.

33.

Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk.

van den Elzen MT, van Os-Medendorp H, Röckmann-Helmbach H, van Hoffen E, Lebens AF, van Doorn H, Klemans RJ, Bruijnzeel-Koomen CA, Hack CE, Kaufman L, Relan A, Knulst AC.

J Allergy Clin Immunol. 2016 Aug;138(2):476-481.e1. doi: 10.1016/j.jaci.2016.04.019. Epub 2016 May 13.

PMID:
27321437
34.

Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis.

Hillen MR, Moret FM, van der Wurff-Jacobs K, Radstake T, Hack CE, Lafeber F, van Roon J.

Scand J Rheumatol. 2017 Jan;46(1):11-16. doi: 10.3109/03009742.2016.1158311. Epub 2016 Jun 2.

PMID:
27250804
35.

Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process.

Hofman ZL, Relan A, Zeerleder S, Drouet C, Zuraw B, Hack CE.

J Allergy Clin Immunol. 2016 Aug;138(2):359-66. doi: 10.1016/j.jaci.2016.02.041. Epub 2016 May 28. Review.

PMID:
27246526
36.

Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, Luijk BD, Oudijk ED, van Kessel DA, Grutters JC, Hack CE, Otten HG.

Sci Rep. 2016 May 24;6:26274. doi: 10.1038/srep26274.

37.

Bradykinin: Inflammatory Product of the Coagulation System.

Hofman Z, de Maat S, Hack CE, Maas C.

Clin Rev Allergy Immunol. 2016 Oct;51(2):152-61. doi: 10.1007/s12016-016-8540-0. Review.

38.

Granzyme M and K release in human experimental endotoxemia.

Wensink AC, Wiewel MA, Jongeneel LH, Boes M, van der Poll T, Hack CE, Bovenschen N.

Immunobiology. 2016 Jul;221(7):773-7. doi: 10.1016/j.imbio.2016.02.006. Epub 2016 Feb 24.

39.

A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation.

Budding K, van de Graaf EA, Kardol-Hoefnagel T, Broen JC, Kwakkel-van Erp JM, Oudijk EJ, van Kessel DA, Hack CE, Otten HG.

Am J Transplant. 2016 Mar;16(3):987-98. doi: 10.1111/ajt.13497. Epub 2015 Oct 30.

40.

Thymic stromal lymphopoietin as a novel mediator amplifying immunopathology in rheumatic disease.

Hillen MR, Radstake TR, Hack CE, van Roon JA.

Rheumatology (Oxford). 2015 Oct;54(10):1771-9. doi: 10.1093/rheumatology/kev241. Epub 2015 Jul 9. Review.

PMID:
26163286
41.

The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.

Hillen MR, Hartgring SA, Willis CR, Radstake TR, Hack CE, Lafeber FP, van Roon JA.

PLoS One. 2015 Jun 25;10(6):e0130830. doi: 10.1371/journal.pone.0130830. eCollection 2015.

42.

Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.

Hillen MR, Kruize AA, Bikker A, Wenting-van Wijk M, Radstake TR, Hack CE, Lafeber FP, van Roon JA.

Mod Rheumatol. 2016;26(1):105-9. doi: 10.3109/14397595.2015.1054089. Epub 2015 Sep 23.

PMID:
25995032
43.

Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.

Reshef A, Zanichelli A, Longhurst H, Relan A, Hack CE.

Allergy. 2015 May;70(5):506-13. doi: 10.1111/all.12587. Epub 2015 Feb 23.

44.

Granzymes regulate proinflammatory cytokine responses.

Wensink AC, Hack CE, Bovenschen N.

J Immunol. 2015 Jan 15;194(2):491-7. doi: 10.4049/jimmunol.1401214. Review.

45.

Hereditary Angioedema Attacks: Local Swelling at Multiple Sites.

Hofman ZL, Relan A, Hack CE.

Clin Rev Allergy Immunol. 2016 Feb;50(1):34-40. doi: 10.1007/s12016-014-8463-6.

PMID:
25527240
46.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

Otten HG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas M, Spierings E, Hack CE, van Reekum F, van Zuilen AD, Verhaar MC, Bots ML, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven E, Gelens M, Christiaans M, van Ittersum F, Nurmohamed A, Lardy NM, Swelsen WT, van Donselaar-van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma AJ, de Fijter JW, Betjes MG, Roelen DL, Claas FH.

Transpl Immunol. 2014 Oct;31(4):184-90. doi: 10.1016/j.trim.2014.09.008. Epub 2014 Oct 1.

PMID:
25258025
47.

Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.

Budding K, van de Graaf EA, Hoefnagel T, Kwakkel-van Erp JM, van Kessel DA, Dragun D, Hack CE, Otten HG.

J Cyst Fibros. 2015 Jan;14(1):42-5. doi: 10.1016/j.jcf.2014.07.007. Epub 2014 Aug 2.

48.

Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.

De Hoog VC, Timmers L, Van Duijvenvoorde A, De Jager SC, Van Middelaar BJ, Smeets MB, Woodruff TM, Doevendans PA, Pasterkamp G, Hack CE, De Kleijn DP.

Cardiovasc Res. 2014 Sep 1;103(4):521-9. doi: 10.1093/cvr/cvu153. Epub 2014 Jun 15.

PMID:
24935433
49.

Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability.

Ruark CD, Hack CE, Robinson PJ, Mahle DA, Gearhart JM.

J Pharm Sci. 2014 Jul;103(7):2189-2198. doi: 10.1002/jps.24011. Epub 2014 May 15.

PMID:
24832575
50.

Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells.

Moret FM, Hack CE, van der Wurff-Jacobs KM, Radstake TR, Lafeber FP, van Roon JA.

Arthritis Rheumatol. 2014 May;66(5):1176-84. doi: 10.1002/art.38338.

Supplemental Content

Support Center